Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Mountain Valley MD advances commercialization priorities across core business lines

Mountain Valley MD Holdings Inc (CSE:MVMD, OTCQB:MVMDF) (MVMD) has provided investors with an update on its progress across its three core business lines nutraceuticals, agriculture, and husbandry animals and aquatic species.

In its nutraceuticals segment, the company highlighted the launch of its Quicksol Eons Deeper Sleep rapid dissolve mushroom tablet product, which was produced by Circadian Wellness under license from MVMD.

It expects that a variety of consumer products using its technology under CW’s Eons brands will be made available for sale in the US throughout 2024 and beyond.

Meanwhile, in its agriculture segment, the company said trials of Agrarius, an organic product it is certified to resell, have exceeded management’s expectations. It has shown promise in managing citrus greening disease and improving overall plant health.

MVMD said it is conducting business development activities in Mexico, Central America, South America and the US with a focus on large-scale farming operations.

In its husbandry animals and aquatic species segment, the company said it plans to introduce its Soluvec 1% product formulation which uses its Quicksol solubilization technology into Bangladesh by May of 2024.

Finally, the company announced the appointment of experienced executive Matt Anderson to the role of chief financial officer. He brings more than 20 years of experience in public company financial reporting, mergers and acquisitions, and complex financial instruments to the position.

Anderson replaces Yong Yao, effective immediately.

“We believe are at a very exciting time in our company’s progress. The MVMD team and our extensive network of partners have made significant progress advancing our commercialization priorities," MVMD CEO Dennis Hancock said in a statement.

"We are confident that the tangible value proposition of our technologies is being very well received and that we have successfully laid the groundwork needed to support our long-term commercial viability, while supporting our desire to make a global impact in line with our vision of More Life."

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK